ACTIVEFINE Stock Overview
Active Fine Chemicals Limited produces and sells bulk drugs/active pharmaceutical ingredients (APIs) and various laboratory reagents in Bangladesh.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Active Fine Chemicals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ৳12.20 |
| 52 Week High | ৳21.50 |
| 52 Week Low | ৳12.20 |
| Beta | 0.23 |
| 1 Month Change | -14.08% |
| 3 Month Change | -14.69% |
| 1 Year Change | -36.79% |
| 3 Year Change | -20.78% |
| 5 Year Change | -57.64% |
| Change since IPO | -56.61% |
Recent News & Updates
Recent updates
Shareholder Returns
| ACTIVEFINE | BD Pharmaceuticals | BD Market | |
|---|---|---|---|
| 7D | -15.3% | -2.9% | -3.0% |
| 1Y | -36.8% | -16.6% | -19.3% |
Return vs Industry: ACTIVEFINE underperformed the BD Pharmaceuticals industry which returned -16.7% over the past year.
Return vs Market: ACTIVEFINE underperformed the BD Market which returned -19.4% over the past year.
Price Volatility
| ACTIVEFINE volatility | |
|---|---|
| ACTIVEFINE Average Weekly Movement | 10.4% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in BD Market | 8.6% |
| 10% least volatile stocks in BD Market | 3.3% |
Stable Share Price: ACTIVEFINE's share price has been volatile over the past 3 months.
Volatility Over Time: ACTIVEFINE's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of BD stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | S. M. Rahman | www.afchem.com |
Active Fine Chemicals Limited produces and sells bulk drugs/active pharmaceutical ingredients (APIs) and various laboratory reagents in Bangladesh. The company’s APIs include azithromycin dihydrate, erythromycin ethyl succinate, and erythromycin stearate for macrolide-antibiotics; esomeprazole magnesium trihydrates and pellets for anti-ulcerant; fluconazoles for anti-fungal; atorvastatin and rosuvastatin calcium for lipid-lowering; cetirizine and fexofenadine hydrochlorides, desloratadines, and ebastine for anti-histamine; and ciprofloxacin hydrochloride for anti-bacterial therapeutics. It also offers cefixime trihydrates and cefuroxime axetil for cephalosporin-antibiotics; metformin hydrochloride, sitagliptin phosphate monohydrate, vildagliptin, linagliptin, gliclizide, and glimepiride for anti-diabetic; pregabalin for anti-epileptic; paracetamol for analgesic and antipyrotic; losartan potassium and amlodipine besylate for anti-hypertensive; calcium orotate for use in calcium-supplement; sofosbuvir for anti-hepatitis-C; etoricoxib and ketorolac tromethamine for NSAID; and ticagrelor and amlodipine besylate for anti-platelet therapeutic areas, as well as solvents and powder reagents.
Active Fine Chemicals Limited Fundamentals Summary
| ACTIVEFINE fundamental statistics | |
|---|---|
| Market cap | ৳2.93b |
| Earnings (TTM) | -৳4.54m |
| Revenue (TTM) | ৳1.35b |
2.2x
P/S Ratio-644.4x
P/E RatioIs ACTIVEFINE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ACTIVEFINE income statement (TTM) | |
|---|---|
| Revenue | ৳1.35b |
| Cost of Revenue | ৳1.02b |
| Gross Profit | ৳336.56m |
| Other Expenses | ৳341.10m |
| Earnings | -৳4.54m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.019 |
| Gross Margin | 24.89% |
| Net Profit Margin | -0.34% |
| Debt/Equity Ratio | 62.9% |
How did ACTIVEFINE perform over the long term?
See historical performance and comparison